Kanaoka M, Negoro T, Kawanaka C, Agui H, Nabeshima S
Takarazuka Research Center, Sumitomo Chemical Co., Ltd., Hyogo, Japan.
Agric Biol Chem. 1991 Mar;55(3):743-50.
Streptococcal antitumor protein (SAGP) was produced by transformed E. coli JM103 carrying the SAGP gene downstream from the tac promoter. The purified recombinant SAGP had the same N-terminal amino acid sequence as that of the native SAGP isolated from Streptococcus pyogenes Su cells. Gel filtration analysis showed that the recombinant SAGP was a dimer, while the native SAGP was a tetramer. When the antitumor activity was tested against sarcoma 180 cells, the IC50 of the recombinant SAGP was 0.3 microgram/ml, about a quarter as active as the native SAGP. These results suggest that the quaternary structure of SAGP is important for the antitumor activity.
链球菌抗肿瘤蛋白(SAGP)由携带SAGP基因且该基因位于tac启动子下游的转化大肠杆菌JM103产生。纯化后的重组SAGP与从化脓性链球菌Su细胞中分离得到的天然SAGP具有相同的N端氨基酸序列。凝胶过滤分析表明,重组SAGP是二聚体,而天然SAGP是四聚体。当针对肉瘤180细胞测试抗肿瘤活性时,重组SAGP的IC50为0.3微克/毫升,活性约为天然SAGP的四分之一。这些结果表明,SAGP的四级结构对抗肿瘤活性很重要。